The work described here is designed to study the mechanisms involved in regulation of pre-mRNA splicing. One aspect of this regulation is alternative splicing of 5' and 3' splice sites on pre-mRNAs to generate multiple isoforms of proteins with distinct functions from single genes. Although this level of gene expression is ubiquitous in eukaryotes the mechanisms that regulate alternative pre-mRNA splicing are not well understood. We have found that a family of pre-mRNA splicing factors, called SR proteins, are involved in the regulation of alternative pre- mRNA splicing. Biochemical and genetic experiments proposed in this application are designed to better understand how SR proteins regulate pre-mRNA splicing. One question we hope to answer is, when during spliceosome assembly do SR proteins exert their function to specify splice sites. We hope to answer this by observing the sequential, splicing-dependent recruitment of U-snRNPs to two different 5' splice sites using SR proteins with different site preferences. We also hope to pursue the regulation of SR protein function by phosphorylation because we have found that only the phosphorylated form of SR proteins can initiate pre-mRNA splicing. Our previous results have led us to hypothesize that independent regulation of SR protein expression in a given nucleus plays a role in specifying alternative splicing. We propose to test this by examining splice site selection in cells where we have altered the levels of particular SR proteins. Finally, we propose to address the distinct functions of each SR protein in vivo through a genetic analysis of SR genes in the nematode C. elegans. This organism is well-suited to genetic analysis because of reverse genetic approach has recently been developed that allows for targeted inactivation of genes.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM048435-04
Application #
2415178
Study Section
Molecular Biology Study Section (MBY)
Project Start
1994-05-01
Project End
1998-11-30
Budget Start
1997-05-01
Budget End
1998-11-30
Support Year
4
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
075524595
City
Seattle
State
WA
Country
United States
Zip Code
98109
Budde, Mark W; Roth, Mark B (2010) Hydrogen sulfide increases hypoxia-inducible factor-1 activity independently of von Hippel-Lindau tumor suppressor-1 in C. elegans. Mol Biol Cell 21:212-7
Chan, Kin; Goldmark, Jesse P; Roth, Mark B (2010) Suspended animation extends survival limits of Caenorhabditis elegans and Saccharomyces cerevisiae at low temperature. Mol Biol Cell 21:2161-71
Miller, Dana L; Roth, Mark B (2009) C. elegans are protected from lethal hypoxia by an embryonic diapause. Curr Biol 19:1233-7
Frazier 3rd, Harold N; Roth, Mark B (2009) Adaptive sugar provisioning controls survival of C. elegans embryos in adverse environments. Curr Biol 19:859-63
Chan, Kin; Roth, Mark B (2008) Anoxia-induced suspended animation in budding yeast as an experimental paradigm for studying oxygen-regulated gene expression. Eukaryot Cell 7:1795-808
Miller, Dana L; Roth, Mark B (2007) Hydrogen sulfide increases thermotolerance and lifespan in Caenorhabditis elegans. Proc Natl Acad Sci U S A 104:20618-22
Moore, Landon L; Stanvitch, Gerald; Roth, Mark B et al. (2005) HCP-4/CENP-C promotes the prophase timing of centromere resolution by enabling the centromere association of HCP-6 in Caenorhabditis elegans. Mol Cell Biol 25:2583-92
Blackstone, Eric; Morrison, Mike; Roth, Mark B (2005) H2S induces a suspended animation-like state in mice. Science 308:518
Nystul, Todd G; Roth, Mark B (2004) Carbon monoxide-induced suspended animation protects against hypoxic damage in Caenorhabditis elegans. Proc Natl Acad Sci U S A 101:9133-6
Stear, Jeffrey H; Roth, Mark B (2004) The Caenorhabditis elegans kinetochore reorganizes at prometaphase and in response to checkpoint stimuli. Mol Biol Cell 15:5187-96

Showing the most recent 10 out of 24 publications